ONVO VivoSim Labs Inc.


$ 2.13 $ -0.10 (-4.46 %)    

Wednesday, 19-Nov-2025 15:48:38 EST
QQQ $ 599.93 $ 3.56 (0.6 %)
DIA $ 461.58 $ 0.46 (0.1 %)
SPY $ 662.83 $ 2.55 (0.39 %)
TLT $ 88.89 $ -0.18 (-0.2 %)
GLD $ 374.84 $ 0.61 (0.16 %)
$ 2.14
$ 2.21
$ 2.11 x 100
$ 2.19 x 400
-- - --
$ 1.41 - $ 21.96
12,435
na
na
$ 1.43
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 organovo-has-received-a-notice-of-allowance-for-a-us-patent-titled-engineered-intestinal-tissue-and-uses-thereof

https://patentcenter.uspto.gov/applications/17695538/ifw/docs

 organovo-holdings-issues-2967144-additional-shares-through-warrant-exercises-and-at-the-market-stock-sales-raising-23m-in-gross-proceeds-bringing-total-outstanding-shares-to-20421617

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company foc...

 why-organovo-onvo-stock-is-skyrocketing

Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR prog...

 organovo-holdings-appoints-norman-staskey-as-president-cfo-and-principal-financial-officer-effective-december-30-2024-in-connection-with-resignation-of-tomas-hess---filing

On December 23, 2024, Hess, the Company's former President, Chief Financial Officer and Principal Financial Officer, notifi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION